Treatments and follow-up
The IA-14-day group consisted of Ilaprazole (5.0 mg twice daily, half an hour before meals) and amoxicillin capsules (1 g three times daily, half an hour after meals) for 14 days. The IAFB-14-day group comprised of Ilaprazole (5.0 mg twice a day half an hour before meals), bismuth citrate potassium capsules (120.0 mg twice a day half an hour before meals), amoxicillin capsules (1 g twice a day half an hour after meals), and furazolidone tablets (0.1 g twice a day half an hour after meals) for 14 days. The patients were given medication instructions during the course of the treatment and were followed up by phone on day nine or ten to determine their medication experience. The patients were instructed not to smoke, drink alcohol or eat acidic food during the treatment and to stop intake of the drug for one month after the 14-day course, with outpatient follow-up to investigate patient compliance and AEs.